COSCIENS Biopharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $21.9M | $6.2M |
| FY2022 | — | $23.8M | $10.2M |
| FY2023 | — | $21.0M | $6.7M |
| FY2024 | — | $13.2M | $16.4M |
| FY2025 | — | $3.8M | $7.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $21.9M | $6.2M |
| FY2022 | — | $23.8M | $10.2M |
| FY2023 | — | $21.0M | $6.7M |
| FY2024 | — | $13.2M | $16.4M |
| FY2025 | — | $3.8M | $7.3M |